ArticleNPJ breast cancer2017

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial.

Denise M Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.